Ru Yan

机构：Guizhou Provincial People's Hospital

发表论文 6 篇 · 总被引 53 次 · h-index 4

代表论文

First‐line programmed death receptor‐1 ( PD ‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemotherapy, for stage IV penile cancer (2022 · British Journal of Urology · 被引 22)
Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinoma (2025 · Cancer Cell · 被引 18)
Anti-EGFR antibody plus anti-PD-1 antibody and chemotherapy as a neoadjuvant regimen for patients with locally-advanced penile squamous cell carcinoma: A prospective, single-arm, single-center, phase II clinical trial. (2022 · Journal of Clinical Oncology · 被引 6)
Spatial Transcriptional Dynamics of CD74⁺ B Cells in Tertiary Lymphoid Structures Drive Immune Evolution in Penile Squamous Cell Carcinoma (2025 · Advanced Science · 被引 3)
Immune checkpoint inhibitor plus anti-EGFR target therapy plus chemotherapy in patients with locally advanced penile squamous cell carcinoma. (2021 · Journal of Clinical Oncology · 被引 2)
Long-term survival analysis of TNT: A phase II study of neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinoma. (2026 · Journal of Clinical Oncology)